about
STK35L1 associates with nuclear actin and regulates cell cycle and migration of endothelial cellsA systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cellsAntiviral action of the tumor suppressor ARFp19ARF determines the balance between normal cell proliferation rate and apoptosis during mammary gland developmentPro-tumorigenic effects of miR-31 loss in mesothelioma.The ankyrin repeat as molecular architecture for protein recognitionPostnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinasesRegeneration as an evolutionary variableRapid asymmetric evolution of a dual-coding tumor suppressor INK4a/ARF locus contradicts its functionProtein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cellsp19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathwaysMutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2BInclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinomaDisruptive environmental chemicals and cellular mechanisms that confer resistance to cell deathDifferential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivoRole of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistanceA kinase-independent function of CDK6 links the cell cycle to tumor angiogenesisThe role of T‑box genes in the tumorigenesis and progression of cancer (Review)Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatmentTissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130Ink4a/Arf expression is a biomarker of agingThe E3 ubiquitin ligase activity of Trip12 is essential for mouse embryogenesisCellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b)An essential role for Ink4 and Cip/Kip cell-cycle inhibitors in preventing replicative stressDisruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.Application of proteomics in the search for novel proteins associated with the anti-cancer effect of the synthetic cyclin-dependent kinases inhibitor, bohemine.DNA methylation: past, present and future directions.T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product.Transcriptional profiling of putative human epithelial stem cells.p16 mutation spectrum in the premalignant condition Barrett's esophagus.A functional screen for regulators of CKDN2A reveals MEOX2 as a transcriptional activator of INK4a.Disruption of chromosome 11 in canine fibrosarcomas highlights an unusual variability of CDKN2B in dogs.Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models.Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor.DNA copy number, including telomeres and mitochondria, assayed using next-generation sequencing.GRIM-19 and p16(INK4a) synergistically regulate cell cycle progression and E2F1-responsive gene expression.Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines.Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells.p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferationCDKN1C negatively regulates RNA polymerase II C-terminal domain phosphorylation in an E2F1-dependent manner.
P2860
Q21562117-61CD877C-E41E-405A-A4EF-ACFFCDDAA427Q24297823-3CE4443B-2FF6-4FCA-BA5D-369224EECE32Q24301787-9F09B0C4-03C8-4012-B211-0663D53843C3Q24564901-E4977237-9B58-4A69-B1BF-3E07664650A0Q24607181-53A6CADC-E799-4591-A774-B1A2396FEEFAQ24646394-54F274CB-ADBE-4552-9E6A-3CB94FC07650Q24649057-DD5B6EB6-9498-40FA-8230-F103370D8949Q24678617-BE2C786D-5A8E-4615-9328-DBE612660812Q24682671-653C1643-645B-420B-ACBD-290BFB40986FQ24792502-15AF99B8-A5A3-4E00-BF81-C60100CB7172Q24799059-09A7BADE-8790-4A62-A126-502837C12B9CQ24801244-6FCE79B4-5AAA-496B-8B9E-940892BA2A4AQ25257313-EFA3C8A5-1C5D-4E7C-BB3E-C1DAB116EE13Q28080874-86464918-A967-4A6D-A1F5-636611A02A0BQ28202769-87736511-5BD5-4057-ABA9-AA75EB40077DQ28277703-5255F431-E42F-4E48-9732-FBFD853F5C30Q28296641-C51DF599-ACC6-4B60-A262-872E6DF1A289Q28468370-AF1BC2AA-96EB-4996-8881-C1CB59169131Q28477824-654ADF68-3479-434B-916E-F48B3D553A91Q28509125-81D91583-CA9C-4DBA-B503-90165FCA0017Q28570483-F92D662D-89EB-4DAF-B8CC-B54C591DE54AQ28593902-42D7C978-B040-40A6-80BA-BB82EEC2AC1EQ28609756-58CF3AB9-740B-4CFF-98C7-B2C5EBECFECAQ30824986-466AB525-376F-4E63-B10F-9926B3FEA7A1Q30886165-E662A872-0709-4397-9D59-01C6B67855BCQ30893374-B7A06FE4-C9EB-421F-80F6-6EB43CC5309CQ31530974-D8E36674-871E-490F-8AEA-55320358FE32Q33202641-4738CEFA-B89B-48FD-A5F7-3841B3DB2BEEQ33356256-14949B3F-32D6-4F3B-842F-AC8BAFE9D4D1Q33388259-39BB25EB-4146-442C-BD4A-D812364B09BAQ33425898-C8BCEE9B-39F8-4436-BFC6-509BA6EDC00EQ33488731-7B243CD5-A1CD-4FDA-8AA8-8FBFC6FDB0E3Q33533301-6A760948-D708-4473-B684-47CD0C8B1495Q33551923-7ED462EA-F0AC-4932-9446-D8136B9C59F7Q33557746-AC1A3DEA-FB42-480A-8C72-9ED38B673EB5Q33593661-7A906556-9809-47BF-BFDA-280CCA8B13BFQ33648515-C0FECCA4-C0DE-45D8-877C-4C828DE15CC5Q33692902-B4540C77-A8D5-43DD-98F2-478268E535EDQ33743648-2C7D0151-7F7B-4071-A3C5-4094FE725A10Q33744679-D609D34B-4DE2-490E-8A56-CFCFF5F37279
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
The p16INK4a/CDKN2A tumor suppressor and its relatives.
@en
The p16INK4a/CDKN2A tumor suppressor and its relatives.
@nl
type
label
The p16INK4a/CDKN2A tumor suppressor and its relatives.
@en
The p16INK4a/CDKN2A tumor suppressor and its relatives.
@nl
prefLabel
The p16INK4a/CDKN2A tumor suppressor and its relatives.
@en
The p16INK4a/CDKN2A tumor suppressor and its relatives.
@nl
P1476
The p16INK4a/CDKN2A tumor suppressor and its relatives.
@en
P304
P356
10.1016/S0304-419X(98)00017-1
P577
1998-10-01T00:00:00Z